Congress expands domestic biomanufacturing authority for medical emergencies
S. 1305 — Agility in Manufacturing Preparedness Act of 2025 · Filed by Thom Tillis (R-NC) · 1 cosponsor · Introduced Apr 4, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill amends the Public Health Service Act to expand the Biomedical Advanced Research and Development Authority (BARDA) to explicitly collaborate with Manufacturing USA institutes on biomanufacturing technologies and medical preparedness. It adds manufacturing technologies and platforms to BARDA's strategic coordination mandate and authorizes BARDA to work with the Manufacturing USA network on developing and deploying biomanufacturing capabilities for public health emergencies.
Why we flagged it
The bill is a straightforward expansion of an existing federal agency's authority to coordinate with a domestic manufacturing network on medical preparedness. It is a routine legislative amendment that clarifies and broadens an agency mandate in service of public health resilience.
What the text implies
- Explicit authorization may accelerate BARDA's shift toward domestic biomanufacturing partnerships, potentially reducing reliance on contract manufacturing organizations (CMOs) based overseas and strengthening supply chain resilience for medical countermeasures.
- Manufacturing USA institutes are regional public-private partnerships; expanded collaboration may increase federal funding flowing to these regional hubs and their private-sector partners, though the bill itself does not appropriate funds.
- The bill does not specify funding mechanisms or appropriations, so the practical scope of collaboration depends on future budget decisions and BARDA's existing appropriations.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
The bill expands BARDA's authority to collaborate with domestic manufacturing networks on biomanufacturing for medical preparedness, potentially improving the speed and resilience of the U.S. response to public health emergencies. Citizens benefit from stronger domestic manufacturing capacity for medical countermeasures and vaccines, reducing dependence on foreign supply chains and improving emergency response capabilities.
Who stands to gain
- Manufacturing USA institutes (regional public-private partnerships)
- Domestic biomanufacturing companies and contract manufacturers participating in Manufacturing USA ne
- Biotech and pharmaceutical firms developing medical countermeasures in collaboration with BARDA
Named in the bill
Biomedical Advanced Research and Development Authority (BARDA), Manufacturing USA, National Institute of Standards and Technology (NIST), Public Health Service Act, Section 319L(c)(4)(F), Section 34 of the National Institute of Standards and Technology Act
Where it stands
1 cosponsor: 1 Democrats.
- Apr 4, 2025 — Introduced · Congress.gov: “Introduced in Senate”
- Apr 4, 2025 — Referred to Senate Committee on Health, Education, Labor, and Pensions · Congress.gov: “Read twice and referred to the Committee on Health, Education, Labor, and Pensions”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (751 characters) on Jul 25, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
As of — page rendered 2026-10-20.
“Congress expands domestic biomanufacturing authority for medical emergencies” QuorumCivic. https://share.quorumcivic.app/bill/119/s1305 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.